FTSE All-Share
4.449,61
PKT
+20,88
PKT
+0,47
%
Werbung
Analysen zu FTSE All-Share-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 12.01.24 | Glencore Equal Weight | Barclays Capital | |
| 12.01.24 | Rio Tinto Overweight | Barclays Capital | |
| 12.01.24 | Glencore Buy | Goldman Sachs Group Inc. | |
| 12.01.24 | Rio Tinto Buy | Goldman Sachs Group Inc. | |
| 11.01.24 | Glencore Buy | Deutsche Bank AG | |
| 11.01.24 | Rio Tinto Buy | Deutsche Bank AG | |
| 10.01.24 | Diageo Underperform | RBC Capital Markets | |
| 10.01.24 | BAT Neutral | JP Morgan Chase & Co. | |
| 10.01.24 | Unilever Underweight | JP Morgan Chase & Co. | |
| 10.01.24 | GSK Buy | Deutsche Bank AG | |
| 10.01.24 | Diageo Neutral | JP Morgan Chase & Co. | |
| 09.01.24 | GSK Equal Weight | Barclays Capital | |
| 09.01.24 | GSK Equal Weight | Barclays Capital | |
| 09.01.24 | GSK Sell | UBS AG | |
| 09.01.24 | Rio Tinto Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 08.01.24 | Shell (ex Royal Dutch Shell) Overweight | JP Morgan Chase & Co. | |
| 08.01.24 | Diageo Outperform | Bernstein Research | |
| 08.01.24 | Shell (ex Royal Dutch Shell) Outperform | RBC Capital Markets | |
| 08.01.24 | Rio Tinto Neutral | UBS AG | |
| 08.01.24 | Shell (ex Royal Dutch Shell) Buy | Jefferies & Company Inc. | |
| 08.01.24 | Shell (ex Royal Dutch Shell) Overweight | Barclays Capital | |
| 08.01.24 | Shell (ex Royal Dutch Shell) Buy | UBS AG | |
| 08.01.24 | HSBC Buy | Jefferies & Company Inc. | |
| 05.01.24 | GSK Underweight | JP Morgan Chase & Co. | |
| 05.01.24 | AstraZeneca Hold | Deutsche Bank AG | |
| 04.01.24 | BP Overweight | Barclays Capital | |
| 04.01.24 | Shell (ex Royal Dutch Shell) Overweight | Barclays Capital | |
| 04.01.24 | BP Outperform | RBC Capital Markets | |
| 04.01.24 | Shell (ex Royal Dutch Shell) Outperform | RBC Capital Markets | |
| 03.01.24 | Unilever Underweight | JP Morgan Chase & Co. | |
| 03.01.24 | AstraZeneca Overweight | Barclays Capital | |
| 03.01.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 03.01.24 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 03.01.24 | GSK Buy | Jefferies & Company Inc. | |
| 02.01.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 28.12.23 | Unilever Market-Perform | Bernstein Research | |
| 27.12.23 | GSK Equal Weight | Barclays Capital | |
| 27.12.23 | AstraZeneca Buy | UBS AG | |
| 22.12.23 | Rio Tinto Overweight | JP Morgan Chase & Co. | |
| 20.12.23 | Rio Tinto Sector Perform | RBC Capital Markets |